Category: Approval/Launch Region: North America · United States Company: Astrazeneca Lp

US FDA approves AstraZeneca Imfinzi in combo with Imjudo plus chemotherapy to treat metastatic NSCLC

US FDA approves AstraZeneca Imfinzi in combo with Imjudo plus chemotherapy to treat metastatic NSCLC
AstraZeneca

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!